Phibro Animal Health | PAHC - Sales Revenues

Stock Price
54.60
Daily Change
-1.91 -3.38%
Monthly
1.49%
Yearly
220.42%
Q2 Forecast
55.81

Phibro Animal Health reported $373.91M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Align Technology USD 1.05B 54.3M Dec/2025
ANI Pharmaceuticals USD 247.06M 19.25M Dec/2025
Assertio Holdings USD 29.2M 1.92M Sep/2024
Aurora Cannabis CAD 94.19M 3.82M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Canopy Growth CAD 74.54M 7.86M Dec/2025
Corcept Therapeutics USD 202.12M 5.48M Dec/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Henry Schein USD 3.4B 60M Dec/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Merck USD 16.4B 880M Dec/2025
Nektar Therapeutics USD 21.81M 2.32M Dec/2025
Pacira USD 196.87M 17.35M Dec/2025
Phibro Animal Health USD 373.91M 10.02M Dec/2025
Prestige Brands USD 283.44M 9.34M Dec/2025
Supernus Pharmaceuticals USD 211.6M 19.5M Dec/2025
Zoetis USD 2.4B 0 Dec/2025